About Neonatal severe primary hyperparathyroidism
Neonatal severe primary hyperparathyroidism is a rare disease catalogued by Orphanet (ORPHA:417). It is associated with the TRPV6, CASR genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neonatal severe primary hyperparathyroidism trials.
Search ClinicalTrials.gov for "Neonatal severe primary hyperparathyroidism" or filter by Orphanet code ORPHA:417 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neonatal severe primary hyperparathyroidism trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neonatal severe primary hyperparathyroidism. Updated daily.